{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:00:27Z","timestamp":1763564427161,"version":"3.40.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00422-7","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:31:19Z","timestamp":1746495079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-diabetes activity of (R)-gentiandiol in KKAy type 2 mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Yaqi","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianna","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/critrevoncog.2019030976","volume":"24","author":"A Ghasemi","year":"2019","unstructured":"Ghasemi, A. & Norouzirad, R. Type 2 diabetes: An updated overview. Crit. Reviews\u2122 Oncog. 24, 213\u2013222. https:\/\/doi.org\/10.1615\/critrevoncog.2019030976 (2019).","journal-title":"Crit. Reviews\u2122 Oncog."},{"key":"422_CR2","unstructured":"Magliano, D. J. & Boyko, E. J. IDF Diabetes Atlas, 10th edition (2021)."},{"key":"422_CR3","unstructured":"World Health Organization. The top 10 causes of death, Available from: The top 10 causes of death (2020)."},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/bab.1853","volume":"67","author":"IM Chung","year":"2020","unstructured":"Chung, I. M. et al. Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview. Biotechnol. Appl. Chem. 67, 920\u2013928. https:\/\/doi.org\/10.1002\/bab.1853 (2020).","journal-title":"Biotechnol. Appl. Chem."},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11892-022-01453-4","volume":"22","author":"M Ortiz-Mart\u00ednez","year":"2022","unstructured":"Ortiz-Mart\u00ednez, M. et al. Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus. Curr. Diab. Rep. 22, 95\u2013115. https:\/\/doi.org\/10.1007\/s11892-022-01453-4 (2022).","journal-title":"Curr. Diab. Rep."},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/joim.12804","volume":"284","author":"A Rosengren","year":"2018","unstructured":"Rosengren, A. Cardiovascular disease in diabetes type 2: Current concepts. J. Intern. Med. 284, 240\u2013253. https:\/\/doi.org\/10.1111\/joim.12804 (2018).","journal-title":"J. Intern. Med."},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"17056","DOI":"10.1038\/s41598-020-74071-3","volume":"10","author":"X Xiong","year":"2020","unstructured":"Xiong, X. et al. Family history of diabetes is associated with diabetic foot complications in type 2 diabetes. Sci. Rep. 10, 17056. https:\/\/doi.org\/10.1038\/s41598-020-74071-3 (2020).","journal-title":"Sci. Rep."},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"147916412110588","DOI":"10.1177\/14791641211058856","volume":"18","author":"S Thipsawat","year":"2021","unstructured":"Thipsawat, S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diabetes Vasc. Dis. Res. 18, 14791641211058856. https:\/\/doi.org\/10.1177\/14791641211058856 (2021).","journal-title":"Diabetes Vascular Disease Res."},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/jama.2022.0149","volume":"327","author":"A Slomski","year":"2022","unstructured":"Slomski, A. New data on retinopathy in youth-onset type 2 diabetes. JAMA 327, 416. https:\/\/doi.org\/10.1001\/jama.2022.0149 (2022).","journal-title":"JAMA"},{"key":"422_CR10","doi-asserted-by":"publisher","first-page":"2000052","DOI":"10.1002\/bies.202000052","volume":"42","author":"H Gallart-Ayala","year":"2020","unstructured":"Gallart-Ayala, H., Teav, T. & Ivanisevic, J. Metabolomics meets lipidomics: Assessing the small molecule component of metabolism. BioEssays 42, 2000052. https:\/\/doi.org\/10.1002\/bies.202000052 (2020).","journal-title":"BioEssays"},{"key":"422_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14789450.2021.1893695","volume":"18","author":"OP Trifonova","year":"2021","unstructured":"Trifonova, O. P., Maslov, D. L., Balashova, E. E. & Lokhov, P. G. Mass spectrometry-based metabolomics diagnostics\u2013myth or reality? Expert Rev. Proteom. 18, 7\u201312. https:\/\/doi.org\/10.1080\/14789450.2021.1893695 (2021).","journal-title":"Expert Rev. Proteom."},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/molecules23071834","volume":"23","author":"Q Ma","year":"2018","unstructured":"Ma, Q. et al. Progress in metabonomics of type 2 diabetes mellitus. Molecules 23, 1834. https:\/\/doi.org\/10.3390\/molecules23071834 (2018).","journal-title":"Molecules"},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"115164","DOI":"10.1016\/j.jep.2022.115164","volume":"291","author":"M Shi","year":"2022","unstructured":"Shi, M., Tang, J., Zhang, T. & Han, H. Swertiamarin, an active iridoid glycoside from Swertia Pseudochinensis H. Hara, protects against alpha-naphthylisothiocyanate-induced cholestasis by activating the farnesoid X receptor and bile acid excretion pathway. J. Ethnopharmacol. 291, 115164. https:\/\/doi.org\/10.1016\/j.jep.2022.115164 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/14786419.2020.1825428","volume":"36","author":"S Kumar","year":"2020","unstructured":"Kumar, S. et al. Synthesis, molecular docking and ADMET prediction of novel Swertiamarin analogues for the restoration of type-2 diabetes: An enzyme inhibition assay. Nat. Prod. Res. 36, 2197\u20132207. https:\/\/doi.org\/10.1080\/14786419.2020.1825428 (2020).","journal-title":"Nat. Prod. Res."},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/ptr.4763","volume":"27","author":"H Vaidya","year":"2013","unstructured":"Vaidya, H., Goyal, R. K. & Cheema, S. K. Anti-diabetic activity of Swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR\u2010\u03b3 gene expression in 3T3\u2010L1 cells. Phytother. Res. 27, 624\u2013627. https:\/\/doi.org\/10.1002\/ptr.4763 (2013).","journal-title":"Phytother. Res."},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/10286020.2011.631132","volume":"14","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Wang, X., Sun, H., Chen, L. & Ma, C. Determination of novel nitrogen-containing metabolite after oral administration of Swertiamarin to rats. J. Asian Nat. Prod. Res. 14, 176\u2013181. https:\/\/doi.org\/10.1080\/10286020.2011.631132 (2012).","journal-title":"J. Asian Nat. Prod. Res."},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.physbeh.2015.02.036","volume":"144","author":"RD Sonawane","year":"2015","unstructured":"Sonawane, R. D. et al. Role of 5-HT2 receptors in diabetes: Swertiamarin seco-iridoid glycoside might be a possible 5-HT2 receptor modulator. Physiol. Behav. 144, 66\u201372. https:\/\/doi.org\/10.1016\/j.physbeh.2015.02.036 (2015).","journal-title":"Physiol. Behav."},{"key":"422_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1142\/s0192415x17500380","volume":"45","author":"J Li","year":"2017","unstructured":"Li, J., Zhao, Y., Huang, H. & Wang, Y. Phytochemistry and Pharmacological activities of the genus Swertia (Gentianaceae): A review. Am. J. Chin. Med. 45, 667\u2013736. https:\/\/doi.org\/10.1142\/s0192415x17500380 (2017).","journal-title":"Am. J. Chin. Med."},{"key":"422_CR19","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2174\/1389450119666180406113428","volume":"19","author":"N Patel","year":"2018","unstructured":"Patel, N., Tyagi, R. K., Tandel, N., Garg, N. K. & Soni, N. The molecular targets of Swertiamarin and its derivatives confer anti-diabetic and anti-hyperlipidemic effects. Curr. Drug Targets 19, 1958\u20131967. https:\/\/doi.org\/10.2174\/1389450119666180406113428 (2018).","journal-title":"Curr. Drug Targets"},{"key":"422_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-0031-1298021","volume":"62","author":"HL Li","year":"2012","unstructured":"Li, H. L. et al. Determination of the plasma Pharmacokinetic and tissue distributions of Swertiamarin in rats by liquid chromatography with tandem mass spectrometry. Arzneimittelforschung 62, 138\u2013144. https:\/\/doi.org\/10.1055\/s-0031-1298021 (2012).","journal-title":"Arzneimittelforschung"},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","volume":"72","author":"R Moreau","year":"2020","unstructured":"Moreau, R. et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J. Hepatol. 72, 688\u2013701. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.009 (2020).","journal-title":"J. Hepatol."},{"key":"422_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","volume":"18","author":"S Alseekh","year":"2021","unstructured":"Alseekh, S. et al. Mass spectrometry-based metabolomics: A guide for annotation, quantification and best reporting practices. Nat. Methods 18, 747\u2013756. https:\/\/doi.org\/10.1038\/s41592-021-01197-1 (2021).","journal-title":"Nat. Methods"},{"key":"422_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-021-03540-y","volume":"12","author":"FX Danlos","year":"2021","unstructured":"Danlos, F. X. et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 12, 258. https:\/\/doi.org\/10.1038\/s41419-021-03540-y (2021).","journal-title":"Cell Death Dis."},{"key":"422_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/circresaha.120.315890","volume":"128","author":"M Nayor","year":"2021","unstructured":"Nayor, M., Brown, K. J. & Vasan, R. S. The molecular basis of predicting atherosclerotic cardiovascular disease risk. Circul. Res. 128, 287\u2013303. https:\/\/doi.org\/10.1161\/circresaha.120.315890 (2021).","journal-title":"Circul. Res."},{"key":"422_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13506129.2021.1958775","volume":"28","author":"M Olsson","year":"2021","unstructured":"Olsson, M., Hellman, U., Wixner, J. & Anan, I. Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis. Amyloid 28, 234\u2013242. https:\/\/doi.org\/10.1080\/13506129.2021.1958775 (2021).","journal-title":"Amyloid"},{"key":"422_CR26","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.3390\/ijms222011112","volume":"22","author":"MG Rispoli","year":"2021","unstructured":"Rispoli, M. G. et al. Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment. Int. J. Mol. Sci. 22, 11112. https:\/\/doi.org\/10.3390\/ijms222011112 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"422_CR27","doi-asserted-by":"publisher","first-page":"122957","DOI":"10.1016\/j.jchromb.2021.122957","volume":"1183","author":"Z Shi","year":"2021","unstructured":"Shi, Z., Zou, S., Shen, Z., Luan, F. & Yan, J. High-throughput metabolomics using UPLC\/Q-TOF-MS coupled with multivariate data analysis reveals the effect and mechanism of syringin against ovariectomized osteoporosis. J. Chromatogr. B. 1183, 122957. https:\/\/doi.org\/10.1016\/j.jchromb.2021.122957 (2021).","journal-title":"J. Chromatogr. B"},{"key":"422_CR28","doi-asserted-by":"publisher","unstructured":"Han, Y., Sun, H., Zhang, A., Yan, G. & Wang X.-J. Chinmedomics, a new strategy for evaluating the therapeutic efficacy of herbal medicines. Pharmacol. Ther. 216, 107680. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107680 (2020).","DOI":"10.1016\/j.pharmthera.2020.107680"},{"key":"422_CR29","doi-asserted-by":"publisher","first-page":"735410","DOI":"10.3389\/fphar.2021.735410","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Emerging applications of metabolomics to assess the efficacy of traditional Chinese medicines for treating type 2 diabetes mellitus. Front. Pharmacol. 12, 735410. https:\/\/doi.org\/10.3389\/fphar.2021.735410 (2021).","journal-title":"Front. Pharmacol."},{"key":"422_CR30","doi-asserted-by":"publisher","first-page":"728256","DOI":"10.3389\/fphar.2022.728256","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong, L. et al. Chinmedomics strategy for elucidating the pharmacological effects and discovering bioactive compounds from Keluoxin against diabetic retinopathy. Front. Pharmacol. 13, 728256. https:\/\/doi.org\/10.3389\/fphar.2022.728256 (2022).","journal-title":"Front. Pharmacol."},{"key":"422_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00726-017-2508-0","volume":"50","author":"M Adeva-Andany","year":"2018","unstructured":"Adeva-Andany, M. et al. Insulin resistance and glycine metabolism in humans. Amino Acids 50, 11\u201327. https:\/\/doi.org\/10.1007\/s00726-017-2508-0 (2018).","journal-title":"Amino Acids"},{"key":"422_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2183\/pjab.87.274","volume":"87","author":"A Ichiyama","year":"2011","unstructured":"Ichiyama, A. Studies on a unique organelle localization of a liver enzyme, serine: Pyruvate (or alanine: glyoxylate) aminotransferase. Proc. Jpn. Acad. Ser. B 87, 274\u2013286. https:\/\/doi.org\/10.2183\/pjab.87.274 (2011).","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"422_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/oxfordjournals.jbchem.a122695","volume":"105","author":"H Miyajima","year":"1989","unstructured":"Miyajima, H., Oda, T. & Ichiyama, A. Induction of mitochondrial serine: Pyruvate aminotransferase of rat liver by glucagon and insulin through different mechanisms. J. Biochem. 105, 500\u2013504. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a122695 (1989).","journal-title":"J. Biochem."},{"key":"422_CR34","doi-asserted-by":"publisher","unstructured":"Cellini, B., Bertoldi, M., Montioli, R. & Paiardini, A. Borri Voltattorni, C. Human wild-type alanine: Glyoxylate aminotransferase and its naturally occurring G82E variant: Functional properties and physiological implications. Biochem. J. 408, 39\u201350. https:\/\/doi.org\/10.1042\/bj20070637 (2007).","DOI":"10.1042\/bj20070637"},{"key":"422_CR35","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1093\/hmg\/ddv276","volume":"24","author":"E Oppici","year":"2015","unstructured":"Oppici, E. et al. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine: Glyoxylate aminotransferase causing primary hyperoxaluria type I. Hum. Mol. Genet. 24, 5500\u20135511. https:\/\/doi.org\/10.1093\/hmg\/ddv276 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"422_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2018.05.007","volume":"123","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Glycine transporter-1 and glycine receptor mediate the antioxidant effect of glycine in diabetic rat Islets and INS-1 cells. Free Radic. Biol. Med. 123, 53\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.05.007 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"422_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/life11010069","volume":"11","author":"I Choi","year":"2021","unstructured":"Choi, I., Son, H. & Baek, J. H. Tricarboxylic acid (TCA) cycle intermediates: Regulators of immune responses. Life 11, 69. https:\/\/doi.org\/10.3390\/life11010069 (2021).","journal-title":"Life"},{"key":"422_CR38","doi-asserted-by":"publisher","unstructured":"Singh, P. K. et al. Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice. Plos One 12 https:\/\/doi.org\/10.1371\/journal.pone.0177953 (2017).","DOI":"10.1371\/journal.pone.0177953"},{"key":"422_CR39","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2337\/db19-0145","volume":"68","author":"AV Mathew","year":"2019","unstructured":"Mathew, A. V. et al. Impaired amino acid and TCA metabolism and cardiovascular autonomic neuropathy progression in type 1 diabetes. Diabetes 68, 2035\u20132044. https:\/\/doi.org\/10.2337\/db19-0145 (2019).","journal-title":"Diabetes"},{"key":"422_CR40","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41598-018-38154-6","volume":"9","author":"A Villase\u00f1or","year":"2019","unstructured":"Villase\u00f1or, A. et al. Metabolomics reveals citric acid secretion in mechanically\u2013stimulated osteocytes is inhibited by high glucose. Sci. Rep. 9, 2295. https:\/\/doi.org\/10.1038\/s41598-018-38154-6 (2019).","journal-title":"Sci. Rep."},{"key":"422_CR41","doi-asserted-by":"publisher","first-page":"129898","DOI":"10.1016\/j.bbagen.2021.129898","volume":"1865","author":"F Conte","year":"2021","unstructured":"Conte, F., van Buuringen, N., Voermans, N. C. & Lefeber, D. J. Galactose in human metabolism, glycosylation and congenital metabolic diseases: Time for a closer look. Biochim. Et Biophys. Acta (BBA)-General Subj. 1865, 129898. https:\/\/doi.org\/10.1016\/j.bbagen.2021.129898 (2021).","journal-title":"Biochim. Et Biophys. Acta (BBA)-General Subj."},{"key":"422_CR42","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.3748\/wjg.v26.i44.7061","volume":"26","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study. World J. Gastroenterol. 26, 7061\u20137075. https:\/\/doi.org\/10.3748\/wjg.v26.i44.7061 (2020).","journal-title":"World J. Gastroenterol."},{"key":"422_CR43","doi-asserted-by":"publisher","unstructured":"Liu, N. et al. The role of oxidative stress in hyperuricemia and Xanthine oxidoreductase (XOR) inhibitors. Oxidative Med. Cell. Longev. 2021 (1470380). https:\/\/doi.org\/10.1155\/2021\/1470380 (2021).","DOI":"10.1155\/2021\/1470380"},{"key":"422_CR44","doi-asserted-by":"publisher","unstructured":"Binh, T. Q. et al. First report on association of hyperuricemia with type 2 diabetes in a Vietnamese population. Int. J. Endocrinol. 5275071. https:\/\/doi.org\/10.1155\/2019\/5275071 (2019).","DOI":"10.1155\/2019\/5275071"},{"key":"422_CR45","doi-asserted-by":"publisher","unstructured":"Furuhashi, M. New insights into purine metabolism in metabolic diseases: Role of Xanthine oxidoreductase activity. Am. J. Physiol.-Endocrinol. Metab. 319, E827\u2013E834. https:\/\/doi.org\/10.1152\/ajpendo.00378.2020 (2020).","DOI":"10.1152\/ajpendo.00378.2020"},{"key":"422_CR46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.26355\/eurrev_201801_14202","volume":"22","author":"GX Li","year":"2018","unstructured":"Li, G. X., Jiao, X. H. & Cheng, X. B. Correlations between blood uric acid and the incidence and progression of type 2 diabetes nephropathy. Eur. Rev. Med. Pharmacol. Sci. 22, 506\u2013511. https:\/\/doi.org\/10.26355\/eurrev_201801_14202 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"422_CR47","doi-asserted-by":"publisher","unstructured":"Li, M., Gu, L., Yang, J. & Lou, Q. Serum uric acid to creatinine ratio correlates with \u03b2-cell function in type 2 diabetes. Diab.\/Metab. Res. Rev. 34 https:\/\/doi.org\/10.1002\/dmrr.3001 (2018).","DOI":"10.1002\/dmrr.3001"},{"key":"422_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fphys.2017.00126","volume":"8","author":"F Liu","year":"2017","unstructured":"Liu, F. et al. Alterations of urinary microbiota in type 2 diabetes mellitus with hypertension and\/or hyperlipidemia. Front. Physiol. 8, 126. https:\/\/doi.org\/10.3389\/fphys.2017.00126 (2017).","journal-title":"Front. Physiol."},{"key":"422_CR49","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/03007995.2021.1941826","volume":"37","author":"MS Ellulu","year":"2021","unstructured":"Ellulu, M. S., Naser, I. A., Abuhajar, S. M. & Najim, A. A. Determination of risk factors associated with inflammation in hypertensive patients with type-2 diabetes mellitus in a Palestinian diabetes study. Curr. Med. Res. Opin. 37, 1451\u20131459. https:\/\/doi.org\/10.1080\/03007995.2021.1941826 (2021).","journal-title":"Curr. Med. Res. Opin."},{"key":"422_CR50","doi-asserted-by":"publisher","unstructured":"Yuan, G. et al. Use of network pharmacology to explore the mechanism of Gegen (Puerariae lobatae Radix) in the treatment of type 2 diabetes mellitus associated with hyperlipidemia. Evid. -Based Complement. Altern. Medi. 6633402. https:\/\/doi.org\/10.1155\/2021\/6633402 (2021).","DOI":"10.1155\/2021\/6633402"},{"key":"422_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ecl.2013.09.005","volume":"43","author":"G Lastra","year":"2014","unstructured":"Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C. & Sowers, J. R. Type 2 diabetes mellitus and hypertension: An update. Endocrinol. Metabolism Clin. 43, 103\u2013122. https:\/\/doi.org\/10.1016\/j.ecl.2013.09.005 (2014).","journal-title":"Endocrinol. Metabolism Clin."},{"key":"422_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.beem.2016.06.001","volume":"30","author":"S Horr","year":"2016","unstructured":"Horr, S. & Nissen, S. Managing hypertension in type 2 diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 30, 445\u2013454. https:\/\/doi.org\/10.1016\/j.beem.2016.06.001 (2016).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"422_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jdi.13258","volume":"11","author":"T Matsuzaka","year":"2020","unstructured":"Matsuzaka, T. & Shimano, H. New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease. J. Diabetes Invest. 11, 532\u2013534. https:\/\/doi.org\/10.1111\/jdi.13258 (2020).","journal-title":"J. Diabetes Invest."},{"key":"422_CR54","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00125-016-4041-1","volume":"59","author":"T Fall","year":"2016","unstructured":"Fall, T. et al. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes. Diabetologia 59, 2114\u20132124. https:\/\/doi.org\/10.1007\/s00125-016-4041-1 (2016).","journal-title":"Diabetologia"},{"key":"422_CR55","doi-asserted-by":"publisher","unstructured":"Albegali, A. A., Shahzad, M., Ullah, M. I., Mahmood, S. & Rashid, M. Association of genetic polymorphism of PC-1 gene (rs1044498 Lys121Gln) with insulin\u2010resistant type 2 diabetes mellitus in Punjabi population of Pakistan. Mol. Genet. Genom. Med. 7 https:\/\/doi.org\/10.1002\/mgg3.775 (2019).","DOI":"10.1002\/mgg3.775"},{"key":"422_CR56","doi-asserted-by":"publisher","unstructured":"Shetty, S. S. & Kumari, S. Fatty acids and their role in type\u20132 diabetes. Exp. Ther. Med. 22, 706. https:\/\/doi.org\/10.3892\/etm.2021.10138 (2021).","DOI":"10.3892\/etm.2021.10138"},{"key":"422_CR57","doi-asserted-by":"publisher","first-page":"e1827","DOI":"10.1210\/clinem\/dgaa751","volume":"106","author":"F Vanweert","year":"2021","unstructured":"Vanweert, F. et al. Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes\u2013related metabolic disturbances. J. Clin. Endocrinol. Metab. 106, e1827\u2013e1836. https:\/\/doi.org\/10.1210\/clinem\/dgaa751 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"422_CR58","doi-asserted-by":"publisher","unstructured":"Libert, D. M., Nowacki, A. S. & Natowicz, M. R. Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: Amino acid and acylcarnitine levels change along a spectrum of metabolic wellness. PeerJ 6 https:\/\/doi.org\/10.7717\/peerj.5410 (2018).","DOI":"10.7717\/peerj.5410"},{"key":"422_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/advances\/nmy084","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren, W. et al. Glutamine metabolism in macrophages: A novel target for obesity\/type 2 diabetes. Adv. Nutr. 10, 321\u2013330. https:\/\/doi.org\/10.1093\/advances\/nmy084 (2019).","journal-title":"Adv. Nutr."},{"key":"422_CR60","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.molmet.2021.101261","volume":"52","author":"PJ White","year":"2021","unstructured":"White, P. J. et al. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol. Metab. 52, 101261. https:\/\/doi.org\/10.1016\/j.molmet.2021.101261 (2021).","journal-title":"Mol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00422-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00422-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00422-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:31:26Z","timestamp":1746495086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00422-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00422-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15730"}}